#heartfailure Tag

Health Notice: This interview discusses research findings and is not medical advice. If you are concerned about your cannabis use, talk with your healthcare provider or call the SAMHSA National Helpline at 1-800-662-4357 (free, confidential, 24/7). If you are in crisis, call or text 988. Call 911 right away for chest pain or pressure, shortness of breath, sudden weakness or numbness on one side of the body, trouble speaking, or a sudden severe headache.

[caption id="attachment_70106" align="alignleft" width="150"]Raphael E. Cuomo, PhD Professor of Medicine University of California, San Diego Prof. Cuomo[/caption]

MedicalResearch.com Interview with: Raphael E. Cuomo, PhD, MPH, CPH, FRSPH Associate Adjunct Professor, Anesthesiology University of California, San Diego

In medicine, we often picture massive, straight-line progress: hypothesis to experiment to result. But the truth is, many of the greatest leaps forward start with something much smaller—an unexpected signal, a moment of deep curiosity, or what scientists playfully call a "blip". That’s exactly how the groundbreaking story of XXB750 began. In a Novartis research lab, scientists noticed a subtle irregularity in the data—something that simply didn't fit their expectations. The easy thing would have been to ignore it, to write it off as an error. Instead, they decided to dig deeper. That single decision, driven by curiosity, is what led to a potential new therapy for heart failure and resistant hypertension—two conditions that profoundly affect millions worldwide. This isn't just a clinical breakdown of molecules and lab tests; it’s a powerful reminder that behind every breakthrough lies persistence, genuine curiosity, and an unwavering desire to give patients a better life. discovery-transform-heart-failure-treatment

MedicalResearch.com Interview with: [caption id="attachment_59392" align="alignleft" width="133"]Dr. Christine Seidman Dr. Seidman[/caption] Christine Seidman, MD Thomas W. Smith Professor of Medicine and Genetics Director, CV Genetics Center Brigham and Women’s Hospital Harvard Medical School Dept of Genetics Boston, MA 02115  MedicalResearch.com:  What is the background for this study?    Response: Heart failure is a common and incurable disorder that is known to arise from many different underlying causes.  By exploiting a new technology, single nuclear transcriptional analyses, we aimed to define molecular profiles in human hearts tissues that were obtained from patients with different genetic and non-genetic causes of heart failure. Our goal was to determine if there were distinctive signatures that could provide new opportunities to develop precise treatments, based on the specific cause of heart failure.